Clinical Trial Update: Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating bedside genetic or pharmacodynamic testing to prevent periprocedural myonecrosis during PCI in stable angina patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina

Snippet

Sponsor: Medical University of Warsaw | Conditions: Stable Angina | Phase 3 | Status: UNKNOWN